"Further trials with RCT design, larger sample sizes and more syndrome-specific pharmacological agents are needed to improve evidence-based psychiatric care of 22q11.2DS individuals with comorbid mental disorders" #22q https://t.co/ma1M4R60Zq
RT @ESCAPonline: ECAP article: Effectiveness and side effects of psychopharmacotherapy in individuals with #22q11.2 deletion syndrome with…
ECAP article: Effectiveness and side effects of psychopharmacotherapy in individuals with #22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review by Mosheva et al. https://t.co/GogYXfOhCq
RT @22Q11_Ireland: @IanKelleherMD @IrishPsychiatry Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 del…
@IanKelleherMD @IrishPsychiatry Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review https://t.co/ma1M4R60Zq